Cabergoline protects SH-SY5Y neuronal cells in an in vitro model of ischemia
Authors:
- Federica VarsaldiFVFederica Varsaldi
- Elisabetta FrancioliEFElisabetta Francioli
- Angelo BattagliaABAngelo Battaglia
- Pier Luigi CanonicoPCPier Luigi Canonico
- Grazia LombardiGLGrazia Lombardi
- 1 April 2004
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 489 (3) , 157-165
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Role of Intracellular Calcium Stores in Cell Death from Oxygen–Glucose Deprivation in a Neuronal Cell LineJournal of Cerebral Blood Flow & Metabolism, 2002
- Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemiaCell Death & Differentiation, 2001
- Reduction of lipid peroxidation in different rat brain areas after cabergoline treatmentPharmacological Research, 2000
- Pharmacodynamic and Pharmacokinetic Features of CabergolineDrugs, 1998
- Interaction of NMDA and Dopamine D2L Receptors in Human Neuroblastoma SH‐SY5Y CellsJournal of Neurochemistry, 1996
- Ca2+‐DEPENDENT AND ‐INDEPENDENT MECHANISMS OF ISCHAEMIA‐EVOKED RELEASE OF [3H]‐DOPAMINE FROM RAT STRIATAL SLICESClinical and Experimental Pharmacology and Physiology, 1995
- Induction of adenylate cyclase sensitive dopamine D2-receptors in retinoic acid induced differentiated human neuroblastoma SHSY-5Y cellsLife Sciences, 1994
- Excitotoxic cell deathJournal of Neurobiology, 1992
- Vitamin E as an in Vitro and in Vivo AntioxidantaAnnals of the New York Academy of Sciences, 1989
- An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide.Journal of Histochemistry & Cytochemistry, 1985